SPTCL : Every Patient’s Advocate

Daniel’s SPTCL Diagnosis is Suspect, Too

No comments yet! »

When I was (mis)diagnosed with SPTCL (subcutaneous panniculitis-like T-cell lyphoma) in 2004, I was handed a book, published in July 2004, that stated that “fewer than 100 cases have been reported in the last decade.”

Yeah — really, really rare. Because that’s a book used by oncologists all over the world.

Then, from Fall 2004 through May 2008, I heard from only two other people dealing with SPTCL diagnoses. One was a husband of a woman diagnosed. One was the friend of a person diagnosed. I never heard back from either one, so I don’t know their outcomes.

You can imagine then, however AMAZED I am, that I have now heard from three people diagnosed with SPTCL in the past four months!

Heather — we worked together and proved she had been misdiagnosed, too. You can read her story on my SPTCL page.

Cynthia — who has struggled and been treated for her SPTCL for two years or so.  Here’s her story in her own words.

And now Daniel — a 15-year-old boy whose mother, Sonia, contacted me. Daniel’s diagnosis is HIGHLY suspect, like Heather’s and mine. She’s still in the process of chasing down more details.  You can read the latest on Daniel here.

The point?  We are developing a community of people who can offer information — and hope — to others who have just received a devastating diagnosis, and are reaching out to others.

You can do the same!  No matter what your diagnosis, you can look for other blogs that address it, or set one up yourself.  Share information,  Vent.  Ramble.  Get angry.  Help someone else — the most important part.  We’re all in this healthcare thing together, you know.

Want more tools and commentary for sharp patients?
Sign up for Every Patient’s Advocate email tips
- - - - - - - - - - -
Join Trisha in the Patient Empowerment Forum at About.com
- - - - - - - - - - -
Or link here to empower yourself at EveryPatientsAdvocate.com

Heather, SPTCL, the Next Chapter - Hang on to Your Hat!

4 comments »

[To catch up on previous chapters of Heather's story, link here (post #1) and here (post#2.)]

Heather had her first oncology appointment today.  She was lucky to get in so quickly after her primary care physician ditched her (that still makes me shudder) and she was prepared.  Last week, after my post about her diagnosis of CGD-TCL, cutaneous gamma-delta t-cell lymphoma, she had been contacted by Judy Jones at the Cutaneous Lymphoma Foundation, and she was feeling as prepared as she could.

What she was NOT prepared for was what happened!

Her oncologist was happy to tell her that the results of her clonality test had come in and it turns out that no, she does not have cancer.  No treatment needed.  They will continue to follow her for awhile, but don’t expect the diagnosis will change.

WHAT??

If you’ve read my story of SPTCL, then you know the clonality test was pivotal in my story, too.  In fact, my entire diagnosis was predicated on this clonality test, and like Heather’s — the clonality test proved I did not have cancer.

While Heather was there, the oncologist got back in touch with the lab in California that reviewed the clonality of her lymphatic cells.  They reviewed the slides, reviewed the findings, reviewed studies and all agreed that no — Heather has no cancer.  She does have some problem some lymphatic cells, but she will not be treated.  Instead, she is working on diet and nutrition.  She’ll be checked again in four months.

To say Heather and her family — and her co-diagnosed friend Trisha — are euphoric, doesn’t begin to touch it.  We’ve not even met in person, but Heather and I will share a bond forever.  She lives in Nevada, and I’m supposed to be out that way in October — so we hope to meet.

Mostly I’m thrilled, just thrilled that the system worked the way it should.  Heather’s friend Leslie found me and my experience, Heather and I consulted, and two patients worked together to arrive at the right answers for this young mom who only deserves the best.

Now read what Heather has to say about it all — and post a cheer or two to her blog.  Woo HOO!

(And Heather — thanks so much for your kind words. I still choke up everytime I think about what we accomplished. We made quite a team, didn’t we?)

Want more tools and commentary for sharp patients?
Sign up for Every Patient’s Advocate email tips
- - - - - - - - - - -
Join Trisha in the Patient Empowerment Forum at About.com
- - - - - - - - - - -
Or link here to empower yourself at EveryPatientsAdvocate.com

Heather, SPTCL, Another Misdiagnosis and Doctors Who Should Not Practice Medicine

1 comment »

Here’s the good news:  Heather does not have SPTCL.

Here’s the bad news:  Heather does have another type of T-cell lymphoma called CGD-TCL, cutaneous gamma-delta t-cell lymphoma.  Also written with Greek letters:  cutaneous γ/δ T-cell lymphoma

To say that both Heather and I were shocked is an understatement.  If you read my post a few weeks ago, you know that she contacted me when she had a lump biopsied, and was told she had SPTCL (subcutaneous panniculitis-like T-cell lymphoma.)  Thing is — like in my case four years ago — she has no other symptoms.  Further, since then she has had additional tests, including a CT scan that shows no abnormalities, and blood work that is clear.  So yes — shocked.

And, as if it’s not bad enough that she’s been dealt this blow — listen to this: when a review from the NIH is requested, the protocol is for it to be submitted by her primary care doctor or her oncologist, then for the NIH to report back to the doctor who requested the review.  That doctor is then responsible for getting the results back to Heather.

Heather’s biopsy was submitted to Dr. Jaffe at the NIH in early June. When she hadn’t heard anything back by yesterday, almost a month later, she sent an email to Dr. Jaffe just asking when she could expect the results.

Turns out the review was completed June 18 — two weeks ago! — and returned to Heather’s doctor…. and yet no one — not the primary care doctor OR the oncologist has contacted Heather with the results.  Still.  Today.  Not a single phone call.  No one!

The reason Heather knows about her diagnosis is because Dr. Jaffe was considerate enough to attach it as a pdf to her reply email.

So we’ve learned a couple of lessons from Heather’s odyssey so far…. first, to be assertive about reviewing a diagnosis.  Yes — it turns out Heather was misdiagnosed, too — although in this case, she does seem to have lymphoma.  But if she had not pursued a review of her diagnosis, she would be treated for the wrong lymphoma.  Then what?

Second — when you don’t get test results back — go looking for them!  And don’t take no for an answer.  You can be polite, but you need to be assertive.  Had Heather not gotten in touch with Dr. Jaffe, she would still be waiting for the word.  And as far as her doctors are concerned — she’s still waiting!  (I’m having trouble stopping myself from calling these medical bozos what they are.  Oh.  Did I call them that?)

CGD-TCL is just as rare as SPTCL, no doubt about it.  It will be impossible to find a doctor to treat it who has experience with it.  I’ve suggested to Heather that she find a doctor who is willing to research and learn alongside her — a true partner for this unusual disease.  Easier said than done, I’m sure!  But what a blessing if she can actually find one.

If you’d like to follow Heather’s odyssey, I’ll keep you updated here… or better yet…. check out her new blog.  Then, keep Heather and her family in your prayers.

Want more tools and commentary for sharp patients?
Sign up for Every Patient’s Advocate email tips
- - - - - - - - - - -
Join Trisha in the Patient Empowerment Forum at About.com
- - - - - - - - - - -
Or link here to empower yourself at EveryPatientsAdvocate.com

Misdiagnosis, a Visit to the Lab and One Last Point

No comments yet! »

For those of you who have read my misdiagnosis story, you know that one of the ultimate heroes was the pathologist (I’ll call him Dr. H.) who helped me understand how the misdiagnosis happened.  Even though he was one of the doctors responsible for getting it wrong, in the end, he didn’t turn away or try to avoid me.  Instead, he explained to me how the mistake was made.  He even apologized.  There was some relief in that, even though it didn’t change the outcome.

Fast forward four years.  Last week I was invited to visit Dr. H’s lab, the lab where my specimen was mis-read, the one where my misdiagnosis really took root.  It’s a hematopathology lab, meaning specimens like lymphomas, tumors, abnormal growths.  What Dr. H wanted me to know was that procedures and policies have been changed.  In his words, had I not brought the inherent problem-causing procedures to their attention, had I not held their toes to the fire, they’d still be doing things the old way.

And people might still be getting misdiagnosed.

For this woman who has fought on behalf of patients for four years…. that was a melt-down point.  All good.  Dr. H. showed me how the processes have changed.  It’s a way of handling paperwork and the eventual reports that are issued.  It turns out my misdiagnosis was more about piecemeal reporting, and less about bad science.

The tour lasted about an hour.  I saw all kinds of specimens under microscopes, printed reports, color-laced spots on a computer monitor (all well protected so I saw no names — good privacy) — and when we were finished, and I did understand how the original mistake had happened, and what was being done for today’s patients to prevent it from happening again….  I asked only one thing.  This, from my follow up email to Dr. H - and I’m quoting:

I recognize that there will always be a certain number of mistakes that will happen in the reading / conclusions drawn from samples / specimens.  I’ll never forget your words to me those four years ago – that you were taught in medical school that there will be mistakes, but if you have to err on one side or the other, you would want to err on the side of getting someone treatment they didn’t need, as opposed to missing a diagnosis that would require treatment.  I understood it even then.  It makes sense.  And I agree that it’s probably best for the majority of patients.

But when I look at those 10,000+ numbers of specimens being reviewed each year, I have to think there is some of the human aspect being lost.  As you will remember, I did ask the one woman in the lab where we reviewed the lined up chromosome reports, about aligning the work you do with the people who are represented by all those samples.  I do understand the responses you both gave me about objectivity, but I still feel it’s important to make this emphasis:  I don’t think it takes away from objectivity to remind yourselves on occasion (as an entire group of lab professionals) that each report is followed by emotion of real human beings who are receiving answers about their lives.  Each one of those samples represent life, death, debilitation, illness – short term or long term.  If the three most important things in life are love, health and the finances needed to support them, then your results have an impact – positive or negative — on all three.  The reaction upon hearing whatever the news is – good, bad or still unknown — is always emotional in nature.  Total joy, crippling sadness and upset, worry, fear, whatever it is – it’s human.

I’m not suggesting you need to know individual names, faces and personalities to align with samples and test results.  I’m just suggesting that they be regarded for what they are – the determination of what the rest of someone’s life is going to be.  Making that connection would, hopefully, compel the people who are figuring out the answers, the people who work in your labs, want to get it right even more often than they do.  How well do they understand that they hold someone’s life in their hands when they arrive at their answers? Could such an emphasis improve the quality and success rates of your results? I realize not every specimen is a life or death situation.  I imagine some are as simple as strep throat or some other fairly ordinary malady.  Even still, to the person who may not be able to afford the medicine needed to get rid of that strep throat, even that could be a big deal.

There was more, of course…. but that’s the gist.

Bottom line — I am highly appreciative of this opportunity to visit Dr. H’s lab, to observe how their work is done, and most of all to be so gratified that the procedures have been changed and fewer people will be misdiagnosed.

It was a pivotal moment in my career and my life.

Want more tools and commentary for sharp patients?
Sign up for Every Patient’s Advocate email tips
- - - - - - - - - - -
Join Trisha in the Patient Empowerment Forum at About.com
- - - - - - - - - - -
Or link here to empower yourself at EveryPatientsAdvocate.com

Earlier Posts »